Ekso Bionics Holdings Inc (EKSO)

Overview News Price History Option Chain Why EKSO Down? Discussions Forecast Stock Split

Ekso Bionics Holdings Inc stock is currently priced at $1.32, with a 24-hour trading volume of 53,527. It has seen a +9.09% increased in the last 24 hours and a -2.94% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.22 pivot point. If it approaches the $1.36 resistance level, significant changes may occur.

Ekso Bionics Holdings Inc Stock (EKSO) Financials Data

Ekso Bionics Holdings Inc (EKSO) Revenue 2024

EKSO reported a revenue (TTM) of $18.28 million for the quarter ending December 31, 2023, a +41.57% rise year-over-year.

Ekso Bionics Holdings Inc (EKSO) Net Income 2024

EKSO net income (TTM) was -$15.20 million for the quarter ending December 31, 2023, a -0.78% decrease year-over-year.

Ekso Bionics Holdings Inc (EKSO) Cash Flow 2024

EKSO recorded a free cash flow (TTM) of -$12.21 million for the quarter ending December 31, 2023, a +17.95% increase year-over-year.

Ekso Bionics Holdings Inc (EKSO) Earnings per Share 2024

EKSO earnings per share (TTM) was -$1.10 for the quarter ending December 31, 2023, a +5.17% growth year-over-year.

Ekso Bionics Holdings Inc Stock (EKSO) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Lathan Corinna	Director	Aug 23 '23	Buy	0.95	5,500	5,222	143,958
Davis Scott G.	President & COO	Aug 17 '23	Sale	1.00	37,446	37,281	331,372
Wong Jerome	Chief Financial Officer	Aug 17 '23	Sale	1.00	12,784	12,728	266,953
Lathan Corinna	Director	Aug 10 '23	Buy	1.25	4,201	5,251	138,458
SHERMAN STEVEN	Executive Chair	May 24 '23	Sale	1.44	45,660	65,874	364,913
Jones Jason C	Chief Operating Officer	May 08 '23	Sale	1.57	3,435	5,401	138,554

Ekso Bionics Holdings Inc Stock (EKSO) Latest News

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

GlobeNewswire Inc.

Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Benzinga

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Ekso Bionics Reports Record Annual Revenue of $18.3 Million

GlobeNewswire Inc.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.